KemPharm
KMPH
$5.81
Share price
-0.34%
Change (1 day)
6.61%
Change (1 year)
Categories
EPS for KemPharm (KMPH)
EPS in 2022 (TTM): -$0.99
According to KemPharm's latest financial reports the company's current EPS (TTM) is -$0.99. In 2016 the company made an earnings per share (EPS) of -$19.36 an increase over its 2015 EPS that were of -$68.09.
EPS history for KemPharm from 2015 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -$0.99 | |
| 2016 | -$19.36 | -71.57% |
| 2015 | -$68.09 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Theravance Biopharma
TBPH | $11.36 | -1,247.47% | Cayman Islands |
 Jazz Pharmaceuticals JAZZ | -$1.41 | 42.42% | 🇮🇪 Ireland |
 ANI Pharmaceuticals ANIP | -$0.47 | -52.53% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -$39.56 | 3,895.96% | 🇺🇸 USA |